Blocking Bcl-2 leads to autophagy activation and cell death of the HEPG2 liver cancer cell line

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5849-5854

  Dup, Peng ^a   Cao, Hua ^a   Wu, Hao Rong ^a   Zhu, Bao Song ^a   Wang, Hao Wei ^a   Gu, Chun Wei ^a   Xing, Chun Gen ^a   Chen, Wei ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

ABT737; Autophagy; Bcl 2; Chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN BCL 2;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; AUTOPHAGY; CELL DEATH; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; HEPG2 CELL LINE; HUMAN; LIVER NEOPLASMS; MITOCHONDRIAL MEMBRANE POTENTIAL; PROCEDURES; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL DEATH; CELL LINE, TUMOR; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, FLUORESCENCE; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 84890502348     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5849     Document Type: Article

References (32)

1. Abou-Alfa GK, Venook AP (2008). The impact of new data in the treatment of advanced hepatocellular carcinoma. Curr Oncol Rep, 10, 199-205.
2. Al-Ejeh F, Kumar R, Wiegmans A, et al (2010). Harnessing the complexity of DNAdamage response pathways to improve cancer treatment outcomes. Oncogene, 29, 6085-98.
3. Alvarez-Tejado M, Naranjo-Suarez S, Jiménez C, et al (2001). Hypoxia induced the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells. J Biol Chem, 276, 22368-74.
4. Biederbick A, Kern HF, Elsasser HP (1995). Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol, 66, 3-14.
5. Bursch W, Ellinger A, Kienzl H, et al (1996). Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: The role of autophagy. Carcinogenesis, 17, 1595-607.
6. Buytaert E, Callewaert G, Vandenheede JR, Agostinis P (2006). Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy, 2, 238-40.
7. Cadwell K, Liu JY, Brown SL, et al (2008). A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature, 456, 259-63.
8. Carew JS, Nawrocki ST, Cleveland JL (2007). Modulating autophagy for therapeutic benefit. Autophagy, 3, 464-7.
9. Chen N, Karantza-Wadsworth V (2009). Role and regulation of autophagy in cancer. Biochim Biophys Acta, 1793, 1516-23.
10. Erlich S, Mizrachy L, Segev O, et al (2007). Differential interactions between Beclin 1 and Bcl-2 family members. Autophagy, 3, 561-8.
11. Gewirtz DA (2007). Autophagy as a mechanism of radiation sensitization in breast tumor cells. Autophagy, 3, 249-50.
12. Gozuacik D, Kimchi A (2004). Autophagy as a cell death and tumor suppressor mechanism. Oncogene, 23, 2891-906.
13. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70
14. John S, Nayvelt I, Hsu HC, et al (2008) Regulation of estrogenic effects by beclin 1 in breast cancer cells. Cancer Res, 68, 7855-63.
15. Kanzawa T, Germano IM, Komata T, et al (2004). Role of autophagy in temozolomide-inducedcytotoxicity for malignant glioma cells. Cell Death Differ, 11, 448-57.
16. Karantza-Wadsworth V, White E, 2008, Programmed cell death. In: DeVita, VT.; Lawrence, TS.; Rosenberg, SA., Cancer: principles and practice of oncology.editors.8th ed. Lippincott, Williams, & Wilkins; Baltimore, 93-101.
17. Kirkin V, McEwan DG, Novak I, Dikic I (2009). A role for ubiquitin in selective autophagy. Mol Cell, 34, 259-69.
18. Lum JJ, DeBerardinis RJ, Thompson CB (2005). Thompson, Autophagy in metazoans: Cell survival in the land of plenty. Nat Rev Mol Cell Biol, 6, 439-48.
19. Malicdan MC, Noguchi S, Nonaka I, Saftig P, Nishino I (2008). Lysosomal myopathies: An excessive build-up in autophagosomes is too much to handle. Neuromuscul Disord, 18, 521-9.
20. Mathew R, Karantza-Wadsworth V, White E (2007). Role of autophagy in cancer. Nat Rev Cancer, 7, 961-7.
21. Niemann A, Takatsuki A, Elsasser HP (2000). The lysosomotropic agent monodansylcadaverine also acts as a solvent polarity probe. J Histochem Cytochem, 48, 251-8.
22. Orvedahl A, Levine B (2009). Eating the enemy within: Autophagy in infectious diseases. Cell Death Differ, 16, 57-69.
23. Pankiv S, Clausen TH, Lamark T, et al (2007). p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem, 282, 24131-45.
24. Pattingre S, Tassa A, Qu X, Garuti R, et al (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell, 122, 927-39.
25. Poon D, Anderson BO, Chen LT, et al (2009). Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol, 10, 111l-8.
26. Rashid SF, Moore JS, Walker E, et al (2001). Synergistic growth inhibition of prostate cancer cells by 1 alpha, 25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene, 15, 1860-72.
27. Saitoh T, Fujita N, Jang MH, et al (2008). Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature, 456, 264-8.
28. Vero V, Racco S, Biolato M, et al (2009). The treatment of hepatocellular carcinoma: An update. Minerva Med, 100, 173-93.
29. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B (2008). JNK1-mediated phosphorylation of Bcl-2 regulates starvationinduced autophagy. Mol Cell, 30, 678-88.
30. Winslow AR, Rubinsztein DC (2008). Autophagy in neurodegeneration and development. Biochim Biophys Acta, 1782, 723-9.
31. Wong N, Yeo W, Wong WL, et al (2009). TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. Int J Cancer, 124, 644-52.
32. Yen WL, Klionsky DJ (2008). How to live long and prosper:Autophagy, mitochondria and aging. Physiology (Bethesda), 23, 248-62.